Balaxi Pharmaceuticals Ltd.
NSE: BALAXI
₹22.34
₹-0.20
(-0.89%)
As on 31-Aug-2026IST
Market cap
₹123 Cr
Revenue (TTM)
₹280 Cr
P/E Ratio
50.9
P/B Ratio
0.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹2 Cr
-
ROE
0.6 %
-
ROCE
3.5 %
-
Industry P/E
41.91
-
EV/EBITDA
13
-
Debt to Equity
0.2
-
Book Value
₹45.4
-
EPS
₹0.4
-
Face value
2
-
Shares outstanding
55,207,500
10 Years Aggregate
CFO
₹-10.77 Cr
EBITDA
₹246.16 Cr
Net Profit
₹162.98 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Balaxi Pharmaceuticals
| -16.9 | -8.9 | -14.8 | -51.3 | -37.7 | -26.9 | -- |
|
BSE Healthcare
| 18.7 | 1.7 | 10.2 | 18.2 | 22.8 | 14.5 | 12.3 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
|---|---|---|---|---|---|---|
|
Balaxi Pharmaceuticals
| -62.7 | -17.0 | -28.8 | 18.3 | -20.0 | 725.8 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Balaxi Pharmaceuticals
|
22.3 | 123.3 | 280.1 | 2.4 | 2.3 | 1 | 50.9 | 0.5 |
| 3,160.6 | 25,815.6 | 1,461.8 | 387.4 | 34.5 | 25.2 | 66.8 | 14.9 | |
| 834.9 | 16,429.7 | 7,784.0 | 688.5 | 10.6 | 14 | 23.7 | 2.8 | |
| 456.0 | 17,456.0 | 2,141.5 | 58.5 | 5.8 | 3.3 | 164.3 | 4.5 | |
| 828.5 | 20,518.8 | 5,632.3 | 662.4 | 17.2 | 14.3 | 31 | 4.2 | |
| 1,519.1 | 17,370.7 | 1,543.3 | -48.6 | 3.6 | -0.6 | -- | 3.0 | |
| 214.4 | 28,550.8 | 9,205.3 | -371.8 | 1.7 | -3.8 | -- | 3.6 | |
| 1,819.6 | 30,087.9 | 1,935.8 | 288.2 | 20.6 | 29.8 | 104.4 | 22.4 | |
| 400.8 | 16,183.1 | 3,600.2 | 221.0 | 9.7 | 5.6 | 73.2 | 3.4 | |
| 1,883.7 | 30,606.2 | 3,564.0 | 414.0 | 15.3 | 8.4 | 74.8 | 6.1 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Balaxi Pharmaceuticals
Balaxi Pharmaceuticals Limited engages in the international wholesale distribution of pharmaceuticals, builders hardware, and FMCG products in India, Africa, and Latin America. The company offers pharmaceutical products across various therapeutic... areas, including antibiotics, analgesic, anti-malaria, and others. It also provides biscuits and toothpaste. The company was formerly known as Balaxi Ventures Limited and changed its name to Balaxi Pharmaceuticals Limited in October 2020. The company was incorporated in 1942 and is headquartered in Hyderabad, India. Balaxi Pharmaceuticals Limited is a subsidiary of Balaxi Overseas Private Limited. Read more
-
Incorporated
1942
-
Chairman
Ashish Maheshwari
-
Managing Director
Ashish Maheshwari
-
Headquarters
Hyderabad, Telangana
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Balaxi Pharmaceuticals
What is the current share price of Balaxi Pharmaceuticals Ltd Today?
The share price of Balaxi Pharmaceuticals Ltd is ₹22.34 (NSE) as of 31-Aug-2026 IST. Balaxi Pharmaceuticals Ltd has given a return of -37.7% in the last 3 years.
What is the current PB & PE ratio of Balaxi Pharmaceuticals Ltd?
The P/E ratio of Balaxi Pharmaceuticals Ltd is 50.88 times as on 31-Aug-2026, a 21 premium to its peers’ median range of 41.91 times.
The P/B ratio of Balaxi Pharmaceuticals Ltd is 0.49 times as on 31-Aug-2026, a 89 discount to its peers’ median range of 4.32 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
4.99 |
0.35 |
2025 |
12.75 |
1.52 |
2024 |
0.00 |
2.74 |
2023 |
2.09 |
3.13 |
2022 |
7.30 |
3.11 |
What is the 52 Week High and Low of Balaxi Pharmaceuticals Ltd?
The 52-week high and low of Balaxi Pharmaceuticals Ltd are Rs 47.87 and Rs 15.20 as of 01-Sep-2026.
What is the market cap of Balaxi Pharmaceuticals Ltd?
Balaxi Pharmaceuticals Ltd has a market capitalisation of ₹ 123 Cr as on 31-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Balaxi Pharmaceuticals Ltd?
Before investing in Balaxi Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.